acquired
Stage
2024
Founded
4
Investors
About
Semma Therapeutics is a biotech company focused on developing cell replacement therapies for type 1 diabetes using stem cell-derived pancreatic islet cells.
Explore Semma Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.